Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NUDT15 |
| Upstream (Parents) |
|---|
| (<<) CTSO → NUDT15 |
| (<<) PGCP → NUDT15 |
| (<<) C13orf34 → NUDT15 |
| (<<) FBXO5 → NUDT15 |
| Downstream (Children) |
|---|
| NUDT15 → MAGEA12 (>>) |
| NUDT15 → USH2A (>>) |
| NUDT15 → GUCA2A (>>) |
| NUDT15 → LOC51152 (>>) |
| NUDT15 → EFNA5 (>>) |
| NUDT15 → MSX1 (>>) |
| NUDT15 → BTBD7 (>>) |
| NUDT15 → NT5E (>>) |
| NUDT15 → CDX4 (>>) |
| NUDT15 → LOC100130741 (>>) |
| NUDT15 → DLEU2L///DLEU2 (>>) |
| NUDT15 → CAP2 (>>) |
| NUDT15 → MDM1 (>>) |
| NUDT15 → PCIF1 (>>) |
| NUDT15 → RNASEH2B (>>) |
